PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION-Reference-Cited by-同舟云学术

PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION

Published:2019-06 Issue: Volume:37 Page:166-167
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Batlevi C.L.¹,Palomba M.L.¹,Park J.¹,Mead E.¹,Santomasso B.¹,Riviere I.²,Wang X.²,Senechal B.²,Furman R.³,Yang J.¹,Kane P.¹,Hall M.¹,Bernal Y.¹,Lund N.¹,Diamonte C.¹,Pineda J.¹,Halton E.¹,Moskowitz C.⁴,Younes A.¹,Sadelain M.⁵,Brentjens R.¹

Affiliation:

1. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York United States

2. Michael G. Harris Cell Therapy and Cell Engineering Facility; New York NY United States

3. Department of Medicine; Weil Cornell Medical Center; New York United States

4. Department of Medicine; University of Miami Sylvester Cancer Center; Miami United States

5. Center for Cell Engineering; New York NY United States

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.124_2629/fullpdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?;HemaSphere;2023-11-30

2. Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia;Cancer Consult;2023-11-18

3. Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia;Cells;2022-10-19

4. Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia;Cancers;2022-03-28

5. Biology and Treatment of Richter Transformation;Frontiers in Oncology;2022-03-22